|
| Category | Research object | Acupuncture points | Mechanism of action | Reference | Year |
|
| Inhibit inflammation | Rat | Pi shu (BL20), Shen shu (BL23), and Ge shu (BL17) | Inhibits TNF-α expression | [14] | 2014 Y |
| Rat | Zu san li (ST36), San yin jiao (SP6), and Feng long (ST40) | Inhibits TNF-α expression | [15] | 2018 Y |
| Rat | Zu san li (ST36), San yin jiao (SP6), and Feng long (ST40) | Inhibits IL-6 expression | [17] | 2014 Y |
| Rat | Feng long (ST40), Zu san li (ST36) | Inhibits TNF-α and IL-6 expression | [18] | 2018 Y |
| Rat | Zu san li (ST36), San yin jiao (SP6), Feng long (ST40), and Tai chong (LR3) | Inhibits IL-18 expression | [20] | 2013Y |
| Rat | Yin ling quan (SP9), Feng long (ST40), and San yin jiao (SP6) | Regulates Sirt1/NF-κB pathway | [24] | 2020Y |
| Improve lipid metabolism disorder | Mice | Zu san li (ST36), Guan yuan (CV4), and Yong quan (KI1) | Reduces lipid synthesis and promotes lipid metabolism | [29] | 2019Y |
| Person | Feng long (ST40), Zu san li (ST36) | Improves hemorheological index | [30] | 2021Y |
| Mice | Zu san li (ST36), Guan yuan (CV4), and Yong quan (KI1) | Inhibits intestinal lipid absorption and reduces lipid accumulation | [31] | 2020Y |
| Antagonize oxidative stress | Rat | Double side tape (GB26) | Decreases MDA content and increases t-SOD and GSH-Px activities | [33] | 2019Y |
| Mice | Zu san li (ST36), Guan yuan (CV4), and Yong quan (KI1) | Inhibits the expression of 8-OHdG and TBARS and increases the expression of GPX1, 2, 3, and GSS | [29] | 2019Y |
| Mice | Zu san li (ST36), Guan yuan (CV4), and Yi yu (EX-B3) | Decreases MDA content and increases SOD activity, as well as regulates apoptosis expression of Bax and Bcl-2 | [34] | 2020Y |
| Improve endoplasmic reticulum stress | Rat | Feng long (ST40), San yin jiao (SP6) | Inhibits the expression of SrebP-1C and downregulates FAS activity | [40] | 2018Y |
| Rat | Feng long (ST40), Zu san li (ST36) | Inhibits the expression of SrebP-1C | [41] | 2017Y |
| Rat | Zu san li (ST36), San yin jiao (SP6) | Inhibits the expression of SrebP-1C
Inhibits the expression of ERp57 and SREBP-1C | [42] | 2016Y |
| Rat | Zu san li (ST36), San yin jiao (SP6) | Inhibits the expression of GRP78 | [43] | 2016Y |
| Improve insulin resistance | Rat | Zu san li (ST36), San yin jiao (SP6), Feng long (ST40), and Tai chong (LR3) | Decreases the levels of FPG, FINS and HOMA-IR, and FFA concentration | [45] | 2008Y |
| Person | Zhong wan (CV12), Qu chi (LI11), Shui fen (CV9), Guan yuan (CV4), Qi hai (CV6), Feng long (ST40), San yin jiao (SP6), Tai chong (LR3), Xue hai (SP10), Hua rou men (ST24), and Da heng (SP15) | Decreases the levels of FPG, FINS, and HOMA-IR | [8] | 2020Y |
| Rat | Feng long (ST40), Tai chong (LR3) | Increases ADP levels and reduces LP, FFA, and CREP levels | [46] | 2018Y |
| Rat | Feng long (ST40), San yin jiao (SP6) | Inhibits the IKK/NF-κB pathway and increases irS-1 activity | [47] | 2021Y |
| Rat | Zu san li (ST36), Feng long (ST40), Zhong wan (CV12), and Guan yuan (CV4) | Activates the SIRT1/ATG7 pathway and reduces liver fat deposition | [48] | 2021Y |
|
